Cogent Biosciences (COGT) Other Gross PP&E Adjustments (2017 - 2026)
Cogent Biosciences' Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$17.5 million for Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 10.46% to -$17.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$17.5 million through Mar 2026, up 10.46% year-over-year, with the annual reading at -$14.8 million for FY2025, 15.31% up from the prior year.
- Other Gross PP&E Adjustments came in at -$17.5 million for Q1 2026, down from -$14.8 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$3.2 million in Q1 2022 to a low of -$26.9 million in Q2 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$19.6 million (2025), against an average of -$19.4 million.
- The largest YoY upside for Other Gross PP&E Adjustments was 23.31% in 2022 against a maximum downside of 633.52% in 2022.
- Cogent Biosciences' Other Gross PP&E Adjustments stood at -$18.9 million in 2022, then grew by 0.11% to -$18.9 million in 2023, then increased by 7.22% to -$17.5 million in 2024, then grew by 15.31% to -$14.8 million in 2025, then dropped by 18.36% to -$17.5 million in 2026.
- Per Business Quant, the three most recent readings for COGT's Other Gross PP&E Adjustments are -$17.5 million (Q1 2026), -$14.8 million (Q4 2025), and -$18.6 million (Q3 2025).